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In a study of 96,476 participants from the UK Biobank cohort who had their physical activity 
objectively measured by accelerometer, both volume and intensity of physical activity were 
associated with risk of mortality. 
While there is a wealth of epidemiological evidence that higher levels of physical activity are 
associated with lower risk of mortality and other adverse health outcomes1, the interrelationship 
between volume and intensity of physical activity and mortality risk has been unclear.  In this issue 
of Nature Medicine, Strain and colleagues demonstrate, in 96,476 participants from UK Biobank, that 
the overall physical activity energy expenditure (PAEE) and the proportion of this expenditure 
undertaken in moderate-to-vigorous physical activity (MVPA), were both associated with risk of 
mortality2.   
Physical activity guidelines worldwide typically recommend undertaking at least 150 minutes of 
moderate intensity physical activity or at least 75 minutes of vigorous physical activity per week3-5. 
Within these guidelines, physical activity intensity is often described in METs – or metabolic 
equivalents – with 1 MET being equivalent to resting metabolic rate6. Moderate intensity activity is 
typically defined as 3.0-5.9 METs, with the lower end of the range equivalent to walking at 4 km.h-1 
(2.5 mph) on level ground; intensities higher than 6.0 METs are vigorous; and all activities of at least 
3 METs are often grouped as MVPA. An important consideration is that the evidence underpinning 
these guidelines is largely based on epidemiological data in which physical activity was assessed 
using self-report questionnaires. This can limit the ability to generate robust estimates of the 
quantitative relationships between physical activity level and risk of adverse health outcomes. When 
asked, people tend to over-report the amount of physical activity they undertake substantially and 
by an inconsistent amount, which has the dual effect of inflating the apparent amount of physical 
activity required to obtain health benefits, and attenuating the apparent strength of the relationship 
between physical activity and health outcomes7. A second, related, issue is that it is difficult to 
obtain a robust measure of light intensity physical activity (1.5-2.9 METs) from self-report 
questionnaires, which means that its association with health outcomes has been unclear.  This is of 
practical importance as the majority of our PAEE is in the light intensity range.   
Strain and colleagues address this by using physical activity data gathered objectively using wrist-
worn accelerometers from a subset of 96,476 participants in UK Biobank – a population-based 
cohort of over 500,000 men and women who had extensive data collected on lifestyle, medical 
history and environment, as well as physical assessments and biological samples collected, during a 
baseline assessment between 2006-2010, and are continuing to have health-related outcomes 
followed up via data linkage to health records 8. Accelerometer measures of physical activity were 
made in a subset of UK Biobank participants between 2013-2015 who, in Strain et al’s analysis, were 
followed up for a median of 3.1 years, during which time 732 died.  Their data show that, compared 
to a reference group with a PAEE of ~15 kJ.kg-1.day-1 (~1,000 kJ or 250 kcal/day for a 70 kg person) 
and 10% of this expenditure in MVPA (equivalent to ~7 min/day of MVPA at 3 METs), keeping PAEE 
constant but increasing the proportion of MVPA to 20% (~16 min/day MVPA) resulted 30% lower risk 
of mortality, in analyses adjusted for a range of covariates. In contrast, when the proportion of PAEE 
in MVPA was fixed at 10%, increasing PAEE from ~15 kJ.kg-1.day-1  to ~20 and ~30 kJ.kg-1.day-1 PAEE 
(~335 and ~500 kcal/day for a 70 kg person, ~13 and ~20 mins/day MVPA) was associated with 21% 
and 54% lower risks of mortality, respectively.  Interestingly, mortality risk was minimised (at 76-78% 
lower risk than the reference group) with a PAEE of ~40 kJ.kg-1.day-1 – the median PAEE for the 
cohort – irrespective of the proportion of PAEE in MVPA, with higher expenditures leading to no 
further lowering of risk2 (Figure 1).  The practical implication is, assuming these relationships are 
causal, that those undertaking less than the population median level of PAEE (about 670 kcal/day for 
a 70kg person), would benefit from undertaking a larger proportion of their PAEE in MVPA and/or 
increasing PAEE at any intensity, whereas those who are already achieving this level of PAEE would 
achieve no further gains in terms of mortality risk from doing more.  This leads to the key 
observation that the greatest potential for mortality risk reduction occurs in those with the lowest 
levels of PAEE, supporting the general public health message that “any activity is better than none, 
and more is better still” 3. 
Of particular note, the dose-response relationship in Strain and colleagues’ analysis differs 
substantially from analyses using self-reported physical activity as the exposure variable. For 
example, in a pooled cohort analysis of 654,827 individuals who had physical activity assessed by 
self-report, undertaking 150-300 min.week-1 of moderate intensity physical activity (i.e. achieving 
physical activity guidelines) was associated with a 32% lower risk of mortality compared to a 
reference group undertaking no leisure-time MVPA9. A similar risk reduction achieved with just ~110 
min.week-1 of accelerometer-measured MVPA in the Strain et al analysis2. As the reference group in 
the analysis by Strain et al. undertook ~50 min of MVPA per week, rather than none2, this suggests 
that the benefit in terms of lowering mortality risk for an additional minute of accelerometer-
measured MVPA is about two and a half times as great as that associated with an additional minute 
of self-reported MVPA. Furthermore, the maximal mortality risk reduction observed with high levels 
of activity was about twice as great (~76-78% vs 41%), and occurred at a lower level of MVPA (~320 
vs >450 min/week), when physical activity was objectively measured rather than self-reported 2,9.  
It should be noted that the observational nature of the data limit the ability to make firm 
conclusions about the causality of the relationship between physical activity and mortality. It is, 
however, important to acknowledge the difficulties of performing gold-standard randomised 
controlled trials on the effect of physical activity on mortality in the general population as the low 
mortality rate (risk of death within the next 10 years for a healthy, normal weight, non-smoking, but 
inactive woman in the UK aged 50-59 years, is less than 3%10) means that a trial would need to be 
unfeasibly large and long to have sufficient power to detect an effect. Furthermore, the authors’ 
follow-up period at 3.1 years is short and this increases potential for reverse causality (that is, a 
disease, often undiagnosed, at baseline leading to lower levels of physical activity), even when those 
with prevalent disease at baseline are excluded11.  Finally, covariates used for adjustment in 
statistical models were measured ~5.7 years on average before measurement of physical activity. If 
these deteriorated more in the period between their measurement and measurement of physical 
activity in those who died compared to those who survived, the mortality risk reductions associated 
with physical activity may have been overestimated. The influence of the latter two aspects on the 
findings will both be reduced with longer-term follow-up.   
With the increasing use and decreasing cost of wearable consumer devices to track physical activity, 
Strain and colleagues’ findings, if they persists with longer term follow-up, and are corroborated 
with data from other studies, may result in a future shift in physical activity guidelines to revise the 
amount of accelerometer-measured physical activity required for health benefits downwards from 
current recommendations.  Such a shift may make engaging in physical activity seem more 
achievable for those who are currently inactive.  Of note, a recent meta-analysis of 36,383 
participants across eight studies, similarly reported a steeper dose-response relationship between 
accelerometer-measured physical activity and mortality risk than that observed in studies using self-
reported physical activity as the exposure12, so a critical mass of evidence in this area is starting to 
accumulate. 
Overall Strain and colleagues study2 is an important one; its large size and objective measurement of 
physical activity provides more robust quantification of the dose-response relationship between 
physical activity and mortality than has previously been possible. The benefits of physical activity 
may be greater, and the levels of activity at which they occur may be lower, than we previously 




1. Samitz, G., Egger, M. & Zwahlen, M. Domains of physical activity and all-cause mortality: 
systematic review and dose-response meta-analysis of cohort studies. Int. J Epidemiol 40, 
1382-1400 (2011). 
2. Strain, T., et al. Wearable device measured physical activity and future health risk. Nature 
Medicine (2020). 
3. Department of Health & Social Care, W.G., Department of Health Northern Ireland & 
Scottish Government. UK Chief Medical Officers' Physical Activity Guidelines.  (ed. Care, 
D.o.H.S.) (London, 2019). 
4. Piercy, K.L., et al. The Physical Activity Guidelines for Americans. JAMA 320, 2020-2028 
(2018). 
5. Organisation, W.H. Global recommendations on physical activity for health.  1-58 (Geneva, 
2010). 
6. Ainsworth, B.E., et al. 2011 Compendium of Physical Activities: a second update of codes and 
MET values. Med Sci Sports Exerc 43, 1575-1581 (2011). 
7. Celis-Morales, C.A., et al. Objective vs. Self-Reported Physical Activity and Sedentary Time: 
Effects of Measurement Method on Relationships with Risk Biomarkers. PLoS. ONE 7, 
e36345 (2012). 
8. Allen, N., et al. UK Biobank: current status and what it means for epidemiology. Health Policy 
and Technology 1, 123-126 (2012). 
9. Moore, S.C., et al. Leisure time physical activity of moderate to vigorous intensity and 
mortality: a large pooled cohort analysis. PLoS Med 9, e1001335 (2012). 
10. Kobayashi, L.C., Jackson, S.E., Lee, S.J., Wardle, J. & Steptoe, A. The development and 
validation of an index to predict 10-year mortality risk in a longitudinal cohort of older 
English adults. Age Ageing 46, 427-432 (2017). 
11. Strain, T., et al. Impact of follow-up time and analytical approaches to account for reverse 
causality on the association between physical activity and health outcomes in UK Biobank. 
Int J Epidemiol 49, 162-172 (2020). 
12. Ekelund, U., et al. Dose-response associations between accelerometry measured physical 
activity and sedentary time and all cause mortality: systematic review and harmonised meta-




Figure 1 Legend 
Higher levels of physical activity are associated with a lower risk of mortality. Strain et al. used 
data from accelerometers to study the association between physical activity and risk of mortality in 
96,476 participants from the UK Biobank. For a 70-kg person, 15 kJ kg–1 per day (‘15 kJ/kg/day’; top 
row) is ~250 kcal per day; 20 kJ kg−1 per day is ~335 kcal per day; 30 kJ kg−1 per day is ~500 kcal per 
day; and 40 kJ kg−1 per day is ~670 kcal per day. All MVPA information in parentheses (min/day) is for 
physical activity above an intensity of 3 METs, equivalent to walking at 4 km per hour (2.5 mph). 
